Agents that block t cell receptor antigen-presenting cell interactions
TCR (T Cell Receptor) or co-stimulatory molecule interactions with APC receptors are disrupted or prevented by biotechnology-derived immunotherapeutic drugs. In this diagram, monoclonal antibodies and fusion proteins that stop T cells from activating are displayed given below figure. Blockade of T Cell Receptor Interactions Monoclonal antibodies made in the lab (muromomab, teplizumab, and visilizumab) bind … Read more